BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31056975)

  • 1. Deciphering nasopharyngeal carcinoma pathogenesis via proteomics.
    Xiao Z; Chen Z
    Expert Rev Proteomics; 2019 Jun; 16(6):475-485. PubMed ID: 31056975
    [No Abstract]   [Full Text] [Related]  

  • 2. Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis.
    Li DK; Chen XR; Wang LN; Wang JH; Li JK; Zhou ZY; Li X; Cai LB; Zhong SS; Zhang JJ; Zeng YM; Zhang QB; Fu XY; Lyu XM; Li MY; Huang ZX; Yao KT
    Cancer Gene Ther; 2022 Oct; 29(10):1439-1451. PubMed ID: 35388172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
    Feng X; Zhang J; Chen WN; Ching CB
    J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
    Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
    Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.
    Zhu X; Sun L; Wang Y
    Acta Otolaryngol; 2016; 136(1):87-94. PubMed ID: 26382001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Epstein-Barr virus infection and nasopharyngeal carcinoma pathogenesis.
    Lin CT
    Ai Zheng; 2009 Aug; 28(8):791-804. PubMed ID: 19664324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Research on microRNAs Related to the Invasion and Metastasis of Nasopharyngeal Carcinoma.
    Zhang S; Wang B; Zheng L; Fu Z; Fu Y; Huang W; Cheng A
    Curr Mol Pharmacol; 2022; 15(3):463-474. PubMed ID: 34126919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma.
    Chen C; Wang C; Pang R; Liu H; Yin W; Chen J; Tao L
    J Transl Med; 2023 Apr; 21(1):278. PubMed ID: 37098551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic effects of WNT5A in Epstein-Barr virus‑associated nasopharyngeal carcinoma.
    Yap LF; Ahmad M; Zabidi MM; Chu TL; Chai SJ; Lee HM; Lim PV; Wei W; Dawson C; Teo SH; Khoo AS
    Int J Oncol; 2014 May; 44(5):1774-80. PubMed ID: 24626628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities.
    Liu Q; Bode AM; Chen X; Luo X
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189023. PubMed ID: 37979733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc.
    Li N; Yang L; Qi XK; Lin YX; Xie X; He GP; Feng QS; Liu LR; Xie X; Zeng YX; Feng L
    Cell Death Dis; 2018 Jul; 9(7):761. PubMed ID: 29988031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.